PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Prix Galien
Prix Galien: Pharma R&D and Payers Need to Talk, Yesterday
R&D departments and payers need to communicate early in the drug development process: If pharma is a day late, then payers are likely to be a dollar short, according to panelists at the Galien Forum on Tuesday.
Posted in FDA, Market Access, R&D, Strategy, leadership, pricing Also tagged Medco, Merck, payers, reimbursement Leave a comment
Pharma Celebrates its Own
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage.
“The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Prix Galien Push for Private/Public Collaboration
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Now in Video, the Prix Galien Winners
At the Prix Galien awards ceremony last month, I had the opportunity to interview the winners on camera. We’ve just posted edited versions of the interviews here. Inspiring stories, remarkable people (and some great-looking tuxes). Enjoy.
Prix Galien Winners Embody Innovation